CONTACT
Start With the Right Scope.
Pharmact routes inquiries according to intended use, development stage, requested access and rights. A defined scope helps direct technical, partnering, pharmaceutical-development and corporate discussions efficiently.
Initial contact defines scope – it does not itself create disclosure, supply or licensing rights.
CONTACT PATHS
Different requests require different technical context, evidence boundaries, rights review and internal routing.
For organizations evaluating D016 technology, defined material supply, technical documentation, specifications or application-specific development discussions.
Typical scopeFor supply structures, technology licensing, co-development, regional rights, commercialization structures or strategic transactions.
Typical scopeFor qualified pharmaceutical, scientific, regulatory or development organizations seeking to discuss the investigational BELACT program.
Typical scopeFor qualified corporate, strategic and investor discussions relating to Pharmact, asset development, financing or broader company-level engagement.
Typical scopeU.S.-RELATED INQUIRIES
Inquiries specifically directed to Pantarhin Pharma LLC or its defined U.S. corporate and pharmaceutical-development activities should be submitted through pantarhin.com.
Pharmact and Pantarhin maintain separate public contact processes. An inquiry submitted to Pharmact is not automatically forwarded to Pantarhin.
CONTACT PANTARHIN →BEFORE YOU CONTACT US
An initial inquiry should establish context without requiring premature disclosure by either party.
Please do not send confidential technical information, proprietary sequences, process details, patient-identifiable information or other sensitive material through the initial web form. Where appropriate, confidentiality and technical-review arrangements can be established before deeper disclosure.
Who is contacting Pharmact and in what professional capacity?
What are you evaluating, developing or seeking to structure?
Research, evaluation, commercial supply, licensing, pharmaceutical development or transaction?
Which country, region or territory is relevant to the discussion?
Material, documentation, technical review, license, co-development or another defined right?
CONTACT REQUEST
Use the form below for an initial professional inquiry. Pharmact can then determine the appropriate contact, review depth and next-step framework.
CONTACT GOVERNANCE
An inquiry, meeting or exchange of introductory information does not by itself create a supply commitment, confidentiality obligation, license, exclusivity, sublicensing right, development right or transfer of intellectual property.